RIPK1 variant is not cleaved by CASP8

Stable Identifier
Reaction [transition]
Homo sapiens
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Activation of receptor-interacting serine/threonine-protein kinase 1 (RIPK1) controls tumor necrosis factor receptor (TNFR)- and pattern recognition receptors-mediated apoptosis, necroptosis and inflammatory pathways. RIPK1 activity is regulated post-translationally by ubiquitylation and phosphorylation events, as well as by caspase-8 (CASP8)-mediated cleavage. CASP8 facilitates the cleavage of human and mouse RIPK1 after residues D324 and D325, respectively and prevents caspase-8-dependent apoptosis and RIPK1:RIPK3-dependent necroptosis (Lin Y et al. 1999; Hopkins-Donaldson S et al. 2000; Newton K et al. 2019; Zhang X et al. 2019; Lalaoui N et al. 2020). The dominantly inherited mutations D324N, D324H, D324V and D324Y in RIPK1 prevent CASP8 from cleaving the mutated protein, thereby promoting activation of RIPK1 and leading to an autoinflammatory response in humans (Tao P et al. 2020; Lalaoui N et al. 2020).

Literature References
PubMed ID Title Journal Year
10521396 Cleavage of the death domain kinase RIP by caspase-8 prompts TNF-induced apoptosis

Devin, A, Liu, ZG, Lin, Y, Rodriguez, Y

Genes Dev. 1999
Catalyst Activity

cysteine-type endopeptidase activity of active caspase-8 [cytosol]

Normal reaction
Functional status

Loss of function of TRADD:TRAF2:RIPK1 variant:FADD [cytosol]

Name Identifier Synonyms
genetic disease DOID:630
Cite Us!